InvestorsHub Logo
Followers 240
Posts 12057
Boards Moderated 0
Alias Born 04/05/2009

Re: None

Tuesday, 04/21/2015 1:33:58 PM

Tuesday, April 21, 2015 1:33:58 PM

Post# of 72
Retractable Technologies, Inc. Announces U.S. Supreme Court Decision – Denial of Writ of Certiorari (4/21/15)

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE MKT: RVP) announced that on April 20, 2015, the Supreme Court of the United States denied the petition for a writ of certiorari by Becton, Dickinson and Company (“BD”) relating to its Rule 60(b) motion in the portion of Retractable’s case against BD addressing patent infringement claims.

The patent claims were severed from Retractable’s other claims against BD in 2008. The other portion of the case in which the District Court granted Retractable a final judgment for $352 million plus other relief is not directly affected by the recent Supreme Court ruling.

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. Retractable's products are distributed by various specialty and general line distributors.

For more information on Retractable, visit our website at

"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BDX News